Yijun Zheng | Oncology | Best Researcher Award

Published on by Global Scholar Awards

Mr. Yijun Zheng | Oncology| Best Researcher Award

Doctor at The Second Hospital & Clinical Medical School, Lanzhou University, China

Dr. Zheng Yijun, a PhD candidate in Surgery at Lanzhou University, has made notable contributions to the field of oncology through his research on the prevention and treatment of gastric cancer using traditional Chinese medicine. He has published three SCI papers, including one highly cited work, and serves as a reviewer for multiple esteemed journals. His research has been supported by the National Natural Science Foundation of China, and he has participated in several significant provincial projects. In addition to his research, Dr. Zheng authored a book on infectious disease prevention, further contributing to public health education. While his research demonstrates strong academic engagement and innovative interdisciplinary approaches, his profile could be further enhanced by increasing international collaborations, taking on editorial or leadership roles, and gaining more industry-related experience. Overall, Dr. Zheng’s impactful work in traditional medicine and oncology positions him as a strong candidate for the Best Researcher Award.

Professional Profileย 

Education๐ŸŽ“

Dr. Zheng Yijun is currently pursuing a Ph.D. in Surgery at Lanzhou University, where he is engaged in research focusing on the prevention and treatment of gastric cancer, particularly through the lens of traditional Chinese medicine. His academic journey includes significant involvement in research projects, and he has already contributed to the publication of multiple papers, including two SCI-indexed articles, one of which has achieved high citation rates. In addition to his ongoing doctoral work, Dr. Zheng holds a strong foundation in medical sciences, having participated in a variety of academic initiatives, including projects funded by the National Natural Science Foundation of China. His academic achievements reflect a dedication to advancing medical research, especially in the intersection of modern surgery and traditional medicine. Dr. Zhengโ€™s contributions are a testament to his commitment to both academic excellence and the development of practical, impactful research in the medical field.

Professional Experience๐Ÿ“

Dr. Zheng Yijun has gained valuable professional experience through his research and academic contributions during his time at Lanzhou University. As a PhD candidate in Surgery, he has been involved in multiple research projects, including two funded by the National Natural Science Foundation of China. His research primarily focuses on the integration of traditional Chinese medicine with modern oncology, specifically in the prevention and treatment of gastric cancer. Dr. Zheng has also contributed to the academic community by publishing several papers in SCI-indexed journals, with one achieving significant citation success. Additionally, he serves as a reviewer for respected journals such as Frontiers in Medicine and the International Journal of Clinical Practice, highlighting his role in peer evaluation and academic engagement. While his professional experience is primarily academic, Dr. Zhengโ€™s involvement in funded research and editorial duties reflects his growing influence and expertise in the medical research community.

Research Interest๐Ÿ”Ž

Dr. Zheng Yijunโ€™s primary research interest lies in the prevention and treatment of gastric cancer through the application of traditional Chinese medicine (TCM). He is focused on exploring the pharmacological properties of various herbal compounds and their potential to complement or enhance conventional cancer therapies. His research aims to establish a scientific foundation for integrating TCM into modern oncological practices, offering alternative or adjunct therapies for cancer patients. Dr. Zhengโ€™s work involves a multidisciplinary approach, combining molecular biology, pharmacology, and clinical medicine to uncover key mechanisms of action behind TCMโ€™s therapeutic effects. Additionally, he has contributed to research on the molecular mechanisms of lymph node metastasis in gastric cancer, aiming to identify critical biomarkers and therapeutic targets. His work is not only advancing knowledge in oncology but also promoting the clinical application of traditional treatments, ultimately striving to improve patient outcomes through a holistic approach to cancer care.

Award and Honor๐Ÿ†

Dr. Zheng Yijun has earned notable recognition for his academic and research achievements, particularly in the field of gastric cancer treatment through traditional Chinese medicine. One of his most significant accomplishments is the high citation rate of his SCI-published paper, which placed it in the top 1% for citations, underscoring the impact of his research in the scientific community. Additionally, Dr. Zheng has been awarded research funding for his projects, including support from the National Natural Science Foundation of China, highlighting his contributions to advancing medical knowledge. His work is also recognized through his active role as a reviewer for respected journals, such as Frontiers in Medicine and the International Journal of Clinical Practice, further establishing his reputation within the medical research field. Although he has not yet received specific formal awards or honors, his growing body of impactful work and involvement in key research initiatives place him in a strong position for future accolades.

Research Skill๐Ÿ”ฌ

Dr. Zheng Yijun possesses a diverse set of research skills that enable him to conduct impactful studies in the field of oncology, particularly in integrating traditional Chinese medicine with modern cancer therapies. His expertise lies in molecular biology, pharmacology, and clinical research, allowing him to explore the therapeutic potential of herbal compounds in the treatment of gastric cancer. Dr. Zheng is skilled in experimental design, data analysis, and the use of various research methodologies to investigate complex biological processes, such as lymph node metastasis in gastric cancer. His ability to collaborate on multidisciplinary projects has been key to his success, particularly in securing funding from the National Natural Science Foundation of China. Furthermore, his experience as a reviewer for prominent medical journals reflects his strong analytical skills and deep understanding of the current scientific landscape. Dr. Zhengโ€™s technical proficiency, combined with his critical thinking and problem-solving abilities, makes him a capable and effective researcher in his field.

Conclusion๐Ÿ’ก

Dr. Zheng Yijun demonstrates commendable strengths in scientific research, particularly in the integration of traditional Chinese medicine with oncology. His citation impact, involvement in funded projects, and academic reviewing roles support a strong candidacy for the Best Researcher Award. While expanding international collaborations, assuming leadership/editorial roles, and gaining industry exposure would strengthen his profile further, he is a suitable and promising candidate for this award.

Publications Top Notedโœ๏ธ

  • Title: Corrigendum to: CCDC25 may be a potential diagnostic and prognostic marker of hepatocellular carcinoma: Results from microarray analysis

  • Authors: H. Deng, J. Zhang, Y. Zheng, X. Xu, Y. Zhang

  • Journal: Frontiers in Surgery

  • Year: 2023

  • DOI: 10.3389/fsurg.2022.878648

  • Article Type: Corrigendum

ร–zgรผr Kurt | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Prof. Dr. ร–zgรผr Kurt | Medicine and Dentistry | Best Researcher Award

M.D. Ph.D. at ACIBADEM UNIVERSITY, Turkey

Prof. Dr. ร–zgรผr Kurt is a distinguished Professor of Medical Microbiology at Acibadem University, Turkey, with extensive expertise in parasitology and tropical diseases. He holds both an M.D. and a Ph.D. in Medical Parasitology, and has dedicated over two decades to advancing research and education in the field. His primary research interests focus on parasitic infections, microbiome studies, and the One Health approach. Dr. Kurt has led numerous high-impact research projects related to parasitic diseases, contributing to molecular diagnostic methods, treatment strategies, and the study of disease resistance. He has also been involved in medical education, teaching Medical Parasitology and Tropical Diseases at multiple medical schools in Turkey. In addition to his academic achievements, Dr. Kurt has demonstrated significant community involvement through voluntary healthcare provision in disaster-stricken areas, such as Turkey and Nepal. His contributions to science, education, and humanitarian work make him a leader in his field.

Professional Profileย 

Education

Prof. Dr. ร–zgรผr Kurt’s academic journey reflects a strong foundation in medicine and parasitology. He completed his medical education at Ege University School of Medicine in Izmir, Turkey, graduating in 1997. Following this, he pursued advanced studies in medical parasitology at Celal Bayar University, where he earned his Ph.D. in 2006. His doctoral research focused on various aspects of parasitic diseases, laying the groundwork for his future research endeavors. Over the years, Dr. Kurt has further expanded his academic qualifications with additional training and professional development in medical microbiology. His commitment to education extends beyond his own studies, as he has taught Medical Parasitology and Tropical Diseases at multiple universities, including Acibadem University. His broad educational background, coupled with his deep specialization in parasitology and tropical diseases, has made him a prominent figure in the academic and scientific communities.

Professional Experienceย ย 

Prof. Dr. ร–zgรผr Kurt has a distinguished career in both clinical and academic settings. He began his professional journey as a research assistant at Celal Bayar University, where he worked in the Department of Parasitology from 1999 to 2006. He then transitioned to teaching and research roles at the same university, eventually advancing to Assistant and Associate Professor positions in the Department of Biology. In 2013, Dr. Kurt joined Acibadem University School of Medicine, where he became a Professor of Medical Microbiology, specializing in parasitic and tropical diseases. His expertise extends to medical microbiology, where he has been actively involved in both research and education. Dr. Kurt has also worked in clinical laboratory settings, including Acibadem LABMED Clinical Laboratories, and has been a consultant for tropical disease management at Acibadem Hospitals. Additionally, he has led several research projects funded by national and international organizations, focusing on parasitic infections, diagnostic methods, and disease resistance.

Research Interest

Prof. Dr. ร–zgรผr Kurtโ€™s research interests focus on parasitic and tropical diseases, with a particular emphasis on their impact in the context of One Health. He explores various aspects of medical parasitology, including the epidemiology, diagnostics, and treatment of parasitic infections. A significant portion of his research involves investigating the role of eukaryotic organisms in the human microbiome, a relatively new and emerging field. Dr. Kurt is particularly interested in tropical diseases such as leishmaniasis, malaria, and amoebiasis, as well as the development of molecular diagnostic methods for detecting these infections. His work also extends to studying the resistance mechanisms of parasites to common treatments, as well as exploring novel therapeutic approaches. Additionally, he leads research projects on the vectors of diseases like leishmaniasis, focusing on the role of mosquitoes and sandflies. His extensive contributions aim to improve disease prevention, diagnosis, and treatment in both clinical and field settings.

Award and Honor

Prof. Dr. ร–zgรผr Kurt has received various awards and honors throughout his distinguished career, recognizing his significant contributions to the field of medical microbiology and parasitology. His expertise in tropical diseases and parasitic infections has earned him a reputation as a leading researcher in Turkey and internationally. Dr. Kurt has been acknowledged for his work in developing innovative diagnostic methods and treatments for parasitic diseases. He has received funding for numerous research projects from prestigious organizations, such as TรœBฤฐTAK, and his research has been widely published in respected journals. His commitment to public health and his involvement in humanitarian efforts, including voluntary health care provision during major disasters in Turkey and Nepal, further highlight his dedication to science and society. Dr. Kurtโ€™s ongoing contributions to medical education, clinical practice, and research continue to inspire future generations of scientists and healthcare professionals.

Conclusion

Dr. ร–zgรผr Kurt is a highly deserving candidate for the Best Researcher Award. His long-standing contributions to medical microbiology, particularly in parasitic and tropical diseases, have not only advanced scientific understanding but also improved public health outcomes. His academic excellence, leadership in research, and commitment to community service position him as a leader in the field. Strengthening his international collaborations and engaging in interdisciplinary research could further enhance his contributions to global health.

Publications Top Noted
  • Title: A possible link between subtype 2 and asymptomatic infections of Blastocystis hominis
    Authors: F Dogruman-Al, H Dagci, H Yoshikawa, ร– Kurt, M Demirel
    Year: 2008
    Citations: 168
  • Title: Molecular epidemiology of Blastocystis infections in Turkey
    Authors: M ร–zyurt, ร– Kurt, K Mรธlbak, HV Nielsen, T Haznedaroglu, CR Stensvold
    Year: 2008
    Citations: 165
  • Title: Toxoplasmosis in transplant recipients, Europe, 2010โ€“2014
    Authors: F Robert-Gangneux, V Meroni, D Dupont, F Botterel, JMA Garcia, …
    Year: 2018
    Citations: 134
  • Title: Eradication of Blastocystis in humans: Really necessary for all?
    Authors: ร– Kurt, FD Al, M Tanyรผksel
    Year: 2016
    Citations: 102
  • Title: Epidemiological and diagnostic features of Blastocystis infection in symptomatic patients in Izmir province, Turkey
    Authors: H Dagci, K ร–zgรผr, M Demirel, A Mandiracioglu, S Aydemir, SAZ Ulas, …
    Year: 2014
    Citations: 101
  • Title: Serological levels of zinc, copper and iron elements among Giardia lamblia infected children in Turkey
    Authors: P Ertan, K Yereli, ร– Kurt, IC Balcioฤžlu, A Onaฤž
    Year: 2002
    Citations: 94
  • Title: Rural life, lower socioeconomic status and parasitic infections
    Authors: IC Balcioglu, ร– Kurt, ME Limoncu, G Dinรง, M GรผmรผลŸ, AA Kilimcioglu, …
    Year: 2007
    Citations: 83
  • Title: A comparison of metronidazole and single-dose ornidazole for the treatment of dientamoebiasis
    Authors: ร– Kurt, N GirginkardeลŸler, IC BalcioฤŸlu, A ร–zbilgin, รœZ Ok
    Year: 2008
    Citations: 80
  • Title: Preliminary virtual screening studies to identify GRP78 inhibitors which may interfere with SARS-CoV-2 infection
    Authors: A Palmeira, E Sousa, A Kรถseler, R Sabirli, T Gรถren, I Tรผrkรงรผer, ร– Kurt, …
    Year: 2020
    Citations: 76
  • Title: Leishmaniasis in Turkey: Visceral and cutaneous leishmaniasis caused by Leishmania donovani in Turkey
    Authors: A ร–zbilgin, M Harman, M KarakuลŸ, A Bart, S Tรถz, ร– Kurt, ฤฐ ร‡avuลŸ, E Polat, …
    Year: 2017
    Citations: 75
  • Title: Endoplasmic reticulum stress markers in SARS-COV-2 infection and pneumonia: case-control study
    Authors: A Kรถseler, R Sabirli, T Gรถren, ฤฐ Tรผrkรงรผer, ร– Kurt
    Year: 2020
    Citations: 69
  • Title: Leishmaniasis in Turkey: first clinical isolation of Leishmania major from 18 autochthonous cases of cutaneous leishmaniasis in four geographical regions
    Authors: A ร–zbilgin, G ร‡ulha, S Uzun, M Harman, SG Topal, F Okudan, F Zeyrek, …
    Year: 2016
    Citations: 68

Qintai Yang | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Prof. Qintai Yang | Medicine and Dentistry | Best Researcher Award

Associate Professor of The Third Affiliated Hospital of Sun Yat-sen University, China

Prof. Qintai Yang is a distinguished MD, PhD, and Chief Physician, serving as Vice President at the Third Affiliated Hospital of Sun Yat-sen University. ๐Ÿฅ His leadership extends across multiple departments, including Otorhinolaryngology-Head and Neck Surgery, Allergy, and the Naso-Orbital-Maxilla and Skull Base Center. ๐ŸŒŸ Prof. Yang holds a Doctorate in Otorhinolaryngology from Sun Yat-sen University and has furthered his research at the National University of Singapore. ๐ŸŽ“ His impactful work includes leading 22 research projects and publishing over 70 articles in top journals like The New England Journal of Medicine and BMJ. ๐Ÿ“š He is also recognized for his contributions with over 10 patents and his role in developing clinical guidelines and popular science articles. ๐Ÿ† His innovative research and dedication to medical science have earned him awards such as the Guangdong Province Outstanding Young Medical Talent. ๐ŸŒŸ

Professional profile

Education๐Ÿ“š

Prof. Yang has authored 60 popular science articles and co-authored four specialized monographs. His ability to communicate complex medical information to the public and his peers is essential for promoting health education and fostering a better understanding of medical science. His recognition as a National Excellent Popular Science Author further highlights his excellence in this area.

Professional Experience๐Ÿ›๏ธ

Professor Qintai Yang, MD, PhD, serves as the Chief Physician and Vice President at the Third Affiliated Hospital of Sun Yat-sen University. He holds several prestigious positions, including Chairman of the Department of Otorhinolaryngology-Head and Neck Surgery, Chairman of the Department of Allergy, and Chairman of the Naso-Orbital-Maxilla and Skull Base Center. His leadership roles highlight his extensive experience and commitment to advancing medical science and patient care.

Research Contributions๐ŸŒ

Prof. Yang has led 22 research projects and published over 70 scholarly articles, with more than 50 featured in renowned SCI journals such as The New England Journal of Medicine, BMJ, and Allergy. His research output demonstrates a consistent and impactful contribution to medical science, particularly in otorhinolaryngology and allergy. His extensive publication record in high-impact journals signifies the quality and importance of his research.

Awards and Recognitions๐Ÿ†

Prof. Yang has received several prestigious awards, including the Guangdong Province Outstanding Young Medical Talent and National Excellent Popular Science Author. These accolades reflect his outstanding contributions to medical science and public health education, recognizing his leadership, research excellence, and dedication to advancing his field.

Publications top noted ๐Ÿ“œ
  1. ๐Ÿ“š Expert consensus on odontogenic maxillary sinusitis multi-disciplinary treatment
    • Authors: Lin, J., Wang, C., Wang, X., … Zhou, X., Zhang, L.
    • Journal: International Journal of Oral Science, 2024
    • Volume/Issue: 16(1), 11
    • Citations: 1
  2. ๐Ÿ“˜ Evaluating ChatGPT’s Performance in Answering Questions About Allergic Rhinitis and Chronic Rhinosinusitis
    • Authors: Ye, F., Zhang, H., Luo, X., … Yang, Q., Shi, Z.
    • Journal: Otolaryngology – Head and Neck Surgery (United States), 2024
    • Volume/Issue: 171(2), pp. 571โ€“577
    • Citations: 0
  3. ๐Ÿ“– Educational attainment increases the risk of developing allergic rhinitis and (or) eczema: a Mendelian randomization study based on genome-wide association studies in European patients
    • Authors: Zheng, R., Liu, Z., Chen, Z., … Zhang, J., Yang, Q.
    • Journal: Chinese Journal of Preventive Medicine, 2024
    • Volume/Issue: 58(6), pp. 791โ€“798
    • Citations: 0
  4. ๐Ÿ“™ Based on CT imaging, surgical approach selection for frontal and ethmoid sinus osteoma
    • Authors: Guo, M., Wu, X., Yuan, T., … Zhang, G., Shi, Z.
    • Journal: Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery, 2024
    • Volume/Issue: 38(6), pp. 523โ€“529
    • Citations: 0
  5. ๐Ÿ“• Incidence and prognosis of olfactory and gustatory dysfunctions related to SARS-CoV-2 Omicron strain infection in China: A national multicenter survey of 35,566 individuals
    • Authors: Liu, M.-F., Ma, R.-X., Cao, X.-B., … Cheng, L., Liu, J.-F.
    • Journal: World Journal of Otorhinolaryngology – Head and Neck Surgery, 2024
    • Volume/Issue: 10(2), pp. 113โ€“120
    • Citations: 0
  6. ๐Ÿ“” Application of image-based artificial intelligence in rhinology
    • Authors: Chao, W.H., Luo, X., Liang, G.X., … Shi, Z.H., Yang, Q.T.
    • Journal: Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery, 2024
    • Volume/Issue: 59(3), pp. 277โ€“283
    • Citations: 0
  7. ๐Ÿ“— Xiaoqinglong decoction improves allergic rhinitis by inhibiting NLRP3-mediated pyroptosis in BALB/C mice
    • Authors: Wang, R., Wang, Y., Yang, Q., … Ruan, Y., Zhou, M.
    • Journal: Journal of Ethnopharmacology, 2024
    • Volume: 321, 117490
    • Citations: 2
  8. ๐Ÿ““ Body mass indexโ€™s effect on CRSwNP extends to pathological endotype and recurrence
    • Authors: Chen, W., Bai, Y., Fang, P., … Yang, Q., Zhang, Y.
    • Journal: Rhinology, 2024
    • Volume/Issue: 62(3), pp. 370โ€“382
    • Citations: 0
  9. ๐Ÿ“’ Characteristics and therapeutic strategies of Potts puffy tumor
    • Authors: Deng, H., Chen, Z., Wu, X., Yang, Q.
    • Journal: Journal of Clinical Otorhinolaryngology Head and Neck Surgery, 2024
    • Volume/Issue: 38(1)
    • Citations: 0
  10. ๐Ÿ“™ Preliminary insights into the practice of hypoallergenic home visiting program
    • Authors: Zhang, H., Zhou, M., Zhou, Q., … Chen, Z., Yang, Q.
    • Journal: Chinese Journal of Preventive Medicine, 2023
    • Volume/Issue: 57(12), pp. 1957โ€“1963
    • Citations: 0

Shi Xiaoli | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Shi Xiaoli | Medicine and Dentistry | Best Researcher Award

Attending Physician of Jiangsu Provincial People’s Hospital, China

Dr. Shi Xiaoli, originally from Jiangsu, China, is a distinguished scholar in the field of surgery. ๐ŸŒŸ With a Ph.D. from Southeast University, in collaboration with Nanjing Medical University, Dr. Shi has demonstrated exceptional expertise and dedication in his field. ๐ŸŽ“ His academic journey includes a master’s degree in surgery from Nanjing Medical University, under the mentorship of esteemed advisors Wang Xuehao, Li Xiangcheng, and Yu Yue. ๐Ÿ‘จโ€๐Ÿซ๐Ÿ‘ฉโ€๐Ÿซ Currently residing in Gulou District, Nanjing, Dr. Shi holds professional certifications and has completed standard training. ๐Ÿ ๐Ÿ‘จโ€โš•๏ธ His contributions to the medical field are marked by a commitment to advancing surgical practices and knowledge.

Professional profile

Education๐Ÿ“š

Dr. Shi Xiaoli’s educational journey is marked by significant achievements in the field of surgery. ๐ŸŽ“ He pursued his doctoral studies at Southeast University, in collaboration with Nanjing Medical University, where he earned his Ph.D. in Surgery from September 2021 to July 2024. ๐Ÿ“œ Prior to this, he completed his Masterโ€™s degree in Surgery at Nanjing Medical University from September 2018 to July 2021. ๐Ÿ… Dr. Shi’s academic background reflects a deep commitment to advancing his expertise and contributing to the field of medical science.

Professional Experience๐Ÿ›๏ธ

Dr. Shi Xiaoli has accumulated extensive professional experience in the field of surgery. ๐Ÿ’ผ His career is distinguished by significant contributions to medical practice and research, underscoring his expertise and dedication. ๐Ÿฅ With a robust foundation in clinical and academic settings, Dr. Shi has honed his skills through rigorous training and hands-on experience, establishing himself as a knowledgeable and proficient surgeon. ๐Ÿฉบ His professional journey reflects a strong commitment to enhancing patient care and advancing surgical techniques. ๐ŸŒŸ

Research Interest๐ŸŒ

Dr. Shi Xiaoli is deeply engaged in research within the field of surgery, focusing on advancing surgical techniques and improving patient outcomes. ๐Ÿ”ฌ His interests span innovative surgical methods, disease treatment advancements, and the integration of cutting-edge technologies in medical practice. ๐Ÿฅ๐Ÿ’ก Driven by a commitment to enhancing surgical precision and efficacy, Dr. Shi explores new approaches to surgery and strives to contribute valuable insights to the medical community. ๐Ÿ“Š๐Ÿ” His research aims to address current challenges in the field and push the boundaries of surgical science. ๐ŸŒŸ

Awards and Honors๐Ÿ†

Dr. Shi Xiaoli has received several prestigious awards and honors, reflecting his excellence and dedication in the field of surgery. ๐Ÿ† His achievements include notable recognitions for outstanding research and contributions to medical science. ๐ŸŒŸ Among his accolades are esteemed awards from professional medical associations and institutions, highlighting his impact and leadership in the field. ๐Ÿ…โœจ These honors not only celebrate his academic and clinical accomplishments but also underscore his commitment to advancing surgical practices and patient care. ๐Ÿฅ๐Ÿ‘

Research skill๐Ÿ”ฌ

Dr. Shi Xiaoli possesses a robust set of research skills that underscore his expertise in the field of surgery. ๐Ÿ”ฌ He excels in designing and conducting rigorous studies, utilizing advanced methodologies to explore surgical techniques and patient care innovations. ๐Ÿ“Š With a keen eye for detail and a commitment to precision, Dr. Shi employs sophisticated analytical tools and technologies to derive meaningful insights from his research. ๐Ÿ’ก His ability to critically evaluate data and integrate findings into practical applications reflects his deep understanding of both clinical and academic aspects of surgery. ๐Ÿฅ๐Ÿ” His research skills contribute significantly to advancing medical science and improving surgical outcomes. ๐ŸŒŸ๐Ÿ“ˆ

Achievements๐Ÿ…
  • ๐ŸŽ“ Ph.D. in Surgery from Southeast University (Jointly trained with Nanjing Medical University)
  • ๐Ÿ… Masterโ€™s Degree in Surgery from Nanjing Medical University
  • ๐Ÿฉบ Professional Certification in Surgery
  • ๐Ÿ‘จโ€โš•๏ธ Completed Standard Training in clinical practice
  • ๐ŸŒŸ Significant Contributions to surgical techniques and patient care innovations
  • ๐Ÿ”ฌ Advanced Research in surgical methods and technologies
Projects๐Ÿ› ๏ธ
  • ๐Ÿฅ Innovative Surgical Techniques: Development and implementation of new methods to improve surgical outcomes.
  • ๐Ÿ”ฌ Advanced Research Studies: Exploration of cutting-edge technologies and approaches in surgery.
  • ๐Ÿ“Š Patient Care Enhancements: Projects focused on optimizing patient care through improved surgical practices.
  • ๐Ÿ’ก Technology Integration: Incorporation of advanced technologies into surgical procedures and treatment plans.
  • ๐Ÿงช Clinical Trials: Conducting trials to assess the efficacy and safety of new surgical techniques and treatments.
Publication๐Ÿ“œ
  • RAC1^high NK cell-based immunotherapy in hepatocellular carcinoma via STAT3-NKG2D axis
    • ๐Ÿ“ Authors: Shi, X., Chen, W., Yin, Y., Yu, Y., Wang, X.
    • ๐Ÿ“… Year: 2024
    • ๐Ÿ—ž๏ธ Journal: Cancer Letters
    • ๐Ÿ“ˆ Citations: 0
  • Cuproptosis-associated genes (CAGs) contribute to the prognosis prediction and potential therapeutic targets in hepatocellular carcinoma
    • ๐Ÿ“ Authors: Shi, X., Shi, D., Yin, Y., Yu, Y., Wang, X.
    • ๐Ÿ“… Year: 2024
    • ๐Ÿ—ž๏ธ Journal: Cellular Signalling
    • ๐Ÿ“ˆ Citations: 0
  • MAD2 activates IGF1R/PI3K/AKT pathway and promotes cholangiocarcinoma progression by interfering USP44/LIMA1 complex
    • ๐Ÿ“ Authors: Jiang, W., Yang, X., Shi, K., Li, C., Li, X.
    • ๐Ÿ“… Year: 2023
    • ๐Ÿ—ž๏ธ Journal: Oncogene
    • ๐Ÿ“ˆ Citations: 3
  • Thymidine kinase 1 drives hepatocellular carcinoma in enzyme-dependent and -independent manners
    • ๐Ÿ“ Authors: Li, Q., Zhang, L., Yang, Q., Zhang, P., Wang, X.
    • ๐Ÿ“… Year: 2023
    • ๐Ÿ—ž๏ธ Journal: Cell Metabolism
    • ๐Ÿ“ˆ Citations: 10
  • KIF14 promotes proliferation, lymphatic metastasis and chemoresistance through G3BP1/YBX1 mediated NF-ฮบB pathway in cholangiocarcinoma
    • ๐Ÿ“ Authors: Jiang, W., Wang, J., Yang, X., Li, C., Li, X.
    • ๐Ÿ“… Year: 2023
    • ๐Ÿ—ž๏ธ Journal: Oncogene
    • ๐Ÿ“ˆ Citations: 8
  • Exosomal lncRNA HCG18 contributes to cholangiocarcinoma growth and metastasis through mediating miR-424-5p/SOX9 axis through PI3K/AKT pathway
    • ๐Ÿ“ Authors: Ni, Q., Zhang, H., Shi, X., Li, X.
    • ๐Ÿ“… Year: 2023
    • ๐Ÿ—ž๏ธ Journal: Cancer Gene Therapy
    • ๐Ÿ“ˆ Citations: 13
  • Exosomal miR-30a-5p promoted intrahepatic cholangiocarcinoma progression by increasing angiogenesis and vascular permeability in PDCD10 dependent manner
    • ๐Ÿ“ Authors: Jiang, W., Shi, X., Sun, L., Li, C., Li, X.
    • ๐Ÿ“… Year: 2023
    • ๐Ÿ—ž๏ธ Journal: International Journal of Biological Sciences
    • ๐Ÿ“ˆ Citations: 1
  • NUF2 Drives Cholangiocarcinoma Progression and Migration via Inhibiting Autophagic Degradation of TFR1
    • ๐Ÿ“ Authors: Shan, J., Jiang, W., Chang, J., Li, C., Li, X.
    • ๐Ÿ“… Year: 2023
    • ๐Ÿ—ž๏ธ Journal: International Journal of Biological Sciences
    • ๐Ÿ“ˆ Citations: 6
  • CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3ฮถ
    • ๐Ÿ“ Authors: Hao, X., Zhang, Y., Shi, X., Tang, W., Wang, X.
    • ๐Ÿ“… Year: 2022
    • ๐Ÿ—ž๏ธ Journal: Journal of Experimental and Clinical Cancer Research
    • ๐Ÿ“ˆ Citations: 32
  • ROBO1 p.E280 Loses the Inhibitory Effects on the Proliferation and Angiogenesis of Wild-Type ROBO1 in Cholangiocarcinoma by Interrupting SLIT2 Signal*
    • ๐Ÿ“ Authors: Zhou, T., Zhang, Y., Chen, Y., Li, C., Li, X.
    • ๐Ÿ“… Year: 2022
    • ๐Ÿ—ž๏ธ Journal: Frontiers in Oncology
    • ๐Ÿ“ˆ Citations: 2